No Data
Anixa Biosciences Enters JV With Cleveland Clinic for Additional Cancer Vaccines
Anixa Biosciences Forms Cancer Vaccine Partnership With Cleveland Clinic
Anixa Biosciences Partners With Cleveland Clinic To Develop Cancer Vaccines
Anixa Biosciences Partners With Cleveland Clinic To Develop Cancer Vaccines
Express News | Anixa Biosciences Inc - Cleveland Clinic Is Entitled to Royalties and Other Commercialization Revenues From Company
Anixa Biosciences Expands Partnership With Cleveland Clinic to Develop Additional Cancer Vaccines
Anixa Biosciences CEO Featured on "Target: Cancer Podcast" by Oncologist Dr. Sanjay Juneja
Dr. Amit Kumar interviewed in latest episode, 'The Vaccine That Could End Breast Cancer' SAN JOSE, Calif., May 6, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX